Profile picture

Doctor Alberto Cordero

Hospital San Juan de Alicante, Alicante (Spain)
Membership: FESC Member
Follow
Biography
Interventional cardiologist involved in cardiovascular prevention and treatment. Research on acute coronary syndromes, secondary prevention and lipids.
Logo ESC

Contributor content

Decision support system for risk stratification in patients with heart failure referred to Cardiology.
Presentation
Decision support system for risk stratification in patients with heart failure referred to Cardiology.
Lipid profile risk in menopausal women with no significant increase in lipoprotein(a)
Presentation
Lipid profile risk in menopausal women with no significant increase in lipoprotein(a)
Identification of patients eligible for treatment with semaglutide after an acute coronary syndrome according to guidelines recommendations
Presentation
Identification of patients eligible for treatment with semaglutide after an acute coronary syndrome according to guidelines recommendations
Trends in the gender-gap of cardiovascular disease mortality in Spain in the last 2 decades
Presentation
Trends in the gender-gap of cardiovascular disease mortality in Spain in the last 2 decades
Effect of triglycerides on cardiovascular risk in patients with a first vs. recurrent acute coronary syndrome
Presentation
Effect of triglycerides on cardiovascular risk in patients with a first vs. recurrent acute coronary syndrome
Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome
Presentation
Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome
The determinant role of high-density lipoprotein cholesterol on the recovery of left ventricle ejection fraction after acute coronary syndromes
Presentation
The determinant role of high-density lipoprotein cholesterol on the recovery of left ventricle ejection fraction after acute coronary syndromes
HDLc levels have a protective effect for in-hospital mortality in Non-STEMI but not in STEMI patients.
Presentation
HDLc levels have a protective effect for in-hospital mortality in Non-STEMI but not in STEMI patients.
The real-world cost and health resource utilization associated to the CNIC-polypill containing Atorvastatin 20mg in secondary prevention patients: a subanalysis of the NEPTUNO study
Presentation
The real-world cost and health resource utilization associated to the CNIC-polypill containing Atorvastatin 20mg in secondary prevention patients: a subanalysis of the NEPTUNO study
We need a generalised approach to improve impact at the population level
Presentation
We need a generalised approach to improve impact at the population level

ESC 365 is supported by